The role of ISG15 and ISGylation in the senescence-associated secretory phenotype
ISG15 和 ISGylation 在衰老相关分泌表型中的作用
基本信息
- 批准号:10788670
- 负责人:
- 金额:$ 42.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-30 至 2025-09-29
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAgingBrainCell AgingCell LineCell modelCell secretionCellsDNA DamageDataDevelopmentDiseaseDyskeratosis CongenitaEnzymesFibroblastsGenesHumanISG15 geneInfectionInflammationInterferon InducersInterferonsKidneyKnock-inKnock-outKnockout MiceKnowledgeLaboratoriesLigationLiverMalignant NeoplasmsMapsMediatingMethodsModificationMusMuscleMutateMutationPathogenicityPatientsPhenotypePlayPremature aging syndromeProliferatingProteinsProteomicsRattusRodentRoleSamplingSiteSkinStressSystemTechnologyTelomeraseTelomere ShorteningTherapeutic InterventionTissuesUbiquitin Like ProteinsUp-RegulationViral OncogeneVirus Replicationage relatedcell immortalizationcytokineexperimental studygenetic manipulationhuman modelinnovationinsightmutantpathogensenescencetargeted treatmenttelomeretumor progression
项目摘要
Cellular senescence is a cellular state that affects age-related diseases such as inflammation, cancer
development, and cancer progression. Cells that enter senescence have a senescence-associated secretory
phenotype (SASP) that has major, and usually detrimental, effects on other cells in the surrounding
microenvironment. ISG15 is a ubiquitin-like protein that can covalently modify host and pathogenic proteins,
changing their stability and function. ISG15 can also be secreted and function as a cytokine. While ISG15 is
classically regarded as an interferon-stimulated gene that is induced during infection by pathogens, it can also
be upregulated by DNA damage and stress. Recent studies have demonstrated that ISG15 is among the most
upregulated genes across tissues in aging rodents. It has also been shown by us and others that ISG15 is
upregulated during replicative senescence of human fibroblasts. Our preliminary data further indicates that
ISG15 is significantly upregulated in skin fibroblasts derived from patients with dyskeratosis congenita, a human
model of dysfunctional telomerase and shortened telomeres. Immortalization of DC cells by telomerase
activation restores ISG15 levels to normal. Little is known about how ISG15 upregulation contributes to
senescence and what proteins are ISGylated in senescent cells. Further, it is unknown how ISGylation changes
upon cell immortalization. We hypothesize that upregulation of ISG15 and concomitant ISGylation of
proteins caused by DNA damage is important for the SASP. In this proposal, we will determine what the
interplay is between secreted ISG15 and ISGylation in senescence and immortalization. Using our unique patient
cells and cell lines, we will map the senescence-associated ISGylome using innovative proteomic strategies
pioneered in our laboratories. We will compare the ISGylomes between cells that have been induced to senesce
by different mechanisms and from human and mouse, and we will determine how secreted ISG15 affects
surrounding cells. Further, we will assess how immortalization by telomerase or viral oncogenes changes the
ISGylome. Finally, we will specifically determine how ISG15 and ISGylation affects the SASP through genetic
manipulation of cells to have reduced and enhanced ISGylation. These studies will provide key insight into how
upregulation of ISG15 and ISGylation of specific cellular proteins play a role in cellular senescence and, in
particular, the SASP.
细胞衰老是一种细胞状态,影响与年龄有关的疾病,例如炎症,癌症
发育和癌症进展。进入衰老的细胞具有衰老相关分泌
表型(SASP)对周围其他细胞具有重大且通常有害的影响
微环境。 ISG15是一种泛素样蛋白,可以共价修改宿主和致病蛋白,
改变其稳定性和功能。 ISG15也可以分泌并用作细胞因子。而ISG15是
经典被视为由病原体在感染期间诱导的干扰素刺激的基因,也可以
被DNA损伤和压力上调。最近的研究表明,ISG15是最大的
衰老啮齿动物的组织上上调基因。我们和其他人也表明ISG15是
在人类成纤维细胞的复制衰老过程中上调。我们的初步数据进一步表明
ISG15在源自患有患者的患者的皮肤成纤维细胞中显着上调,它是人类
功能障碍端粒酶和端粒缩短的模型。通过端粒酶对DC细胞的永生化
激活将ISG15水平恢复为正常水平。关于ISG15上调的贡献知之甚少
衰老和哪种蛋白质在衰老细胞中被渗透。此外,未知iSgylation如何改变
细胞永生化。我们假设ISG15的上调和伴随的Isgylation
由DNA损伤引起的蛋白质对SASP很重要。在此提案中,我们将确定
相互作用在衰老和永生化中分泌的ISG15和Isgylation之间。使用我们独特的病人
细胞和细胞系,我们将使用创新的蛋白质组学策略来绘制与衰老相关的iSgylome
在我们的实验室中率先。我们将比较已诱导的细胞之间的iSgylomes
通过不同的机制以及人类和小鼠,我们将确定分泌的ISG15如何影响
周围的细胞。此外,我们将评估端粒酶或病毒癌基因的永生化如何改变
Isgylome。最后,我们将明确确定ISG15和Isgylation如何通过遗传影响SASP
操纵细胞以减少和增强的Isgylation。这些研究将提供有关如何
ISG15的上调和特定细胞蛋白的ISGyLation在细胞衰老中起作用,在
特别是SASP。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALOYSIUS John KLINGELHUTZ其他文献
ALOYSIUS John KLINGELHUTZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALOYSIUS John KLINGELHUTZ', 18)}}的其他基金
A Human Model for Telomerase Dysfunction and Aging
端粒酶功能障碍和衰老的人体模型
- 批准号:
7795131 - 财政年份:2007
- 资助金额:
$ 42.76万 - 项目类别:
A Human Model for Telomerase Dysfunction and Aging
端粒酶功能障碍和衰老的人体模型
- 批准号:
7586094 - 财政年份:2007
- 资助金额:
$ 42.76万 - 项目类别:
A Human Model for Telomerase Dysfunction and Aging
端粒酶功能障碍和衰老的人体模型
- 批准号:
7391533 - 财政年份:2007
- 资助金额:
$ 42.76万 - 项目类别:
A Human Model for Telomerase Dysfunction and Aging
端粒酶功能障碍和衰老的人体模型
- 批准号:
7263255 - 财政年份:2007
- 资助金额:
$ 42.76万 - 项目类别:
A Human Model for Telomerase Dysfunction and Aging
端粒酶功能障碍和衰老的人体模型
- 批准号:
8049045 - 财政年份:2007
- 资助金额:
$ 42.76万 - 项目类别:
The Role of Airborne PCBs in Adipogenesis, Adipose Function, and Metabolic Syndrome
空气中 PCB 在脂肪生成、脂肪功能和代谢综合征中的作用
- 批准号:
10559684 - 财政年份:2006
- 资助金额:
$ 42.76万 - 项目类别:
OVERCOMING CELLULAR SENESCENCE IN HUMAN EPITHELIAL CELLS
克服人类上皮细胞的细胞衰老
- 批准号:
6372506 - 财政年份:2000
- 资助金额:
$ 42.76万 - 项目类别:
OVERCOMING CELLULAR SENESCENCE IN HUMAN EPITHELIAL CELLS
克服人类上皮细胞的细胞衰老
- 批准号:
6761740 - 财政年份:2000
- 资助金额:
$ 42.76万 - 项目类别:
OVERCOMING CELLULAR SENESCENCE IN HUMAN EPITHELIAL CELLS
克服人类上皮细胞的细胞衰老
- 批准号:
6532540 - 财政年份:2000
- 资助金额:
$ 42.76万 - 项目类别:
OVERCOMING CELLULAR SENESCENCE IN HUMAN EPITHELIAL CELLS
克服人类上皮细胞的细胞衰老
- 批准号:
6642035 - 财政年份:2000
- 资助金额:
$ 42.76万 - 项目类别:
相似国自然基金
生物炭原位修复底泥PAHs的老化特征与影响机制
- 批准号:42307107
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
光老化微塑料持久性自由基对海洋中抗生素抗性基因赋存影响机制
- 批准号:42307503
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
METTL3通过m6A甲基化修饰NADK2调节脯氨酸代谢和胶原合成影响皮肤光老化的机制研究
- 批准号:82360625
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
来源和老化过程对大气棕碳光吸收特性及环境气候效应影响的模型研究
- 批准号:42377093
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
河口潮滩中轮胎磨损颗粒的光老化特征及对沉积物氮素转化的影响与机制
- 批准号:42307479
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
- 批准号:
10676358 - 财政年份:2024
- 资助金额:
$ 42.76万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 42.76万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 42.76万 - 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 42.76万 - 项目类别: